| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 04/19/2000 | EP0993299A1 N-oxides of heterocyclic esters, amides, thioesters, and ketones |
| 04/19/2000 | EP0738262B1 Novel heterocyclic compounds |
| 04/19/2000 | EP0713487B1 Novel quinolone carboxylic acid derivatives |
| 04/19/2000 | CN1251097A Phthalazines with angiogenesis inhibiting activity |
| 04/19/2000 | CN1051544C Benzenesulfonamide derivative and process for preparing thereof |
| 04/18/2000 | US6051713 Substituted aryl or heteroarylamides having retinoid-like biological activity |
| 04/18/2000 | US6051712 Piperidine derivatives having renin inhibiting activity |
| 04/18/2000 | US6051710 Useful intermediates in the preparation of pyrimidinones |
| 04/18/2000 | US6051592 Can be used both in crop protection and in the protection of materials for controlling undesirable microorganisms |
| 04/18/2000 | US6051586 Sulfonamide substituted chroman derivatives useful as beta 3 adrenoreceptor agonists |
| 04/18/2000 | US6051582 Antitumor, anticancer agents |
| 04/18/2000 | US6051580 Neurokinin antagonist; antiasthma agent |
| 04/18/2000 | US6051575 Piperazino derivatives as neurokinin antagonists |
| 04/18/2000 | US6051574 Anticancer agents |
| 04/18/2000 | US6051570 Benzimidazole derivatives as antiulcer agents, process for their preparation and pharmaceutical compositions containing them |
| 04/18/2000 | US6051290 Anisotropic retardation layers for display devices |
| 04/18/2000 | CA1340962C Arylhydrazones |
| 04/13/2000 | WO2000020411A1 Cytotoxic alkaloids (halitulin) |
| 04/13/2000 | WO2000020410A1 Propanolamine derivatives substituted with heterocyclic compounds, methods for their production, pharmaceutical compositions containing said compounds and the use thereof |
| 04/13/2000 | WO2000020409A1 Benzylpiperidine compounds and insecticides for agricultural and horticultural use |
| 04/13/2000 | WO2000020402A1 Chemical compounds |
| 04/13/2000 | WO2000020401A1 New bis-benzimidazoles |
| 04/13/2000 | WO2000020399A2 Use of substituted 5-hydroxypyrazoles, novel 5-hydroxypyrazoles, methods for the production thereof and agents containing the same |
| 04/13/2000 | WO2000020393A1 Substituted 1,3-diaryl-2-pyridine-2-yl-3-(pyridine-2-ylamino)-propanol derivatives, methods for their production, pharmaceutical compositions containing the same and their use |
| 04/13/2000 | WO2000020391A1 2,3-disubstituted pyridine derivatives, process for the preparation thereof, drug compositions containing the same and intermediates for the preparation |
| 04/13/2000 | WO2000020389A1 Naphthalenecarboxamides as tachykinin receptor antagonists |
| 04/13/2000 | WO2000020003A1 Naphthalenecarboxamides as tachykinin receptor antagonists |
| 04/13/2000 | WO2000002877A3 New pharmaceutically active compounds |
| 04/13/2000 | DE19845406A1 Substituierte 1,3-Diaryl-2-pyridin-2-yl-3-(pyridin-2-ylamino)- propanolderivate, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung Substituted 1,3-diaryl-2-pyridin-2-yl-3- (pyridin-2-ylamino) - propanol derivatives, process for their preparation, pharmaceutical compositions containing them and their use |
| 04/13/2000 | DE19845402A1 Mit Heterocyclen substituierte Propanolaminderivate, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung -Containing heterocycles substituted with Propanolaminderivate, process for their production, medicaments containing these compounds and their use |
| 04/13/2000 | CA2346865A1 Cytotoxic alkaloids (halitulin) |
| 04/13/2000 | CA2346083A1 Propanolamine derivatives substituted with heterocyclic compounds, methods for their production, pharmaceutical compositions containing said compounds and the use thereof |
| 04/13/2000 | CA2346040A1 New bis-benzimidazoles |
| 04/13/2000 | CA2345577A1 2,3-disubstituted pyridine derivatives, process for the preparation thereof, drug compositions containing the same and intermediates for the preparation |
| 04/13/2000 | CA2345133A1 Naphthalenecarboxamides as tachykinin receptor antagonists |
| 04/13/2000 | CA2344807A1 Naphthalenecarboxamides as tachykinin receptor antagonists |
| 04/13/2000 | CA2341374A1 Quinoline and quinazoline derivatives and their use as inhibitors of cytokine mediated diseases |
| 04/12/2000 | EP0992501A2 Pyridonecarboxylic acid derivatives as antibacterial agents |
| 04/12/2000 | EP0992498A1 Aromatic fatty acid esters |
| 04/12/2000 | EP0992493A1 Substituted benzoylpiperidine derivatives and their use as Neurokinin antagonists |
| 04/12/2000 | EP0992492A1 Small molecule inhibitors of rotamase enzyme activity |
| 04/12/2000 | EP0991753A1 Protease inhibitors |
| 04/12/2000 | EP0991654A1 Novel 2-(iminomethyl)amino-phenyl derivatives, preparation, application as medicines and compositions containing same |
| 04/12/2000 | EP0991648A1 4-haloalkyl-3- heterocyclylpyridines and 4-haloalkyl -5-heterocyclylpyridines, method for the production thereof, agents containing the same and their use as pesticides |
| 04/12/2000 | EP0991645A1 Bis-indole derivatives having antimetastatic activity, a process for their preparation and pharmaceutical compositions containing them |
| 04/12/2000 | EP0991644A1 Benzo(5,6)cycloheptapyridine cyclic ureas and lactams useful as farnesyl protein transferase inhibitors |
| 04/12/2000 | EP0991643A1 Novel aminooxyamide tricyclic inhibitors of farnesylprotein transferase |
| 04/12/2000 | EP0991642A1 2-aminoalkylaminoquinolines as dopamine d4 ligands |
| 04/12/2000 | EP0991641A1 Omeprazole sodium salt |
| 04/12/2000 | EP0991640A1 Synthesis of intermediates useful in preparing bromo-substituted tricyclic compounds |
| 04/12/2000 | EP0991639A1 4- (1h-imidazol-4-yl)piperidin-1-yl]anilide derivatives, their preparation and application in therapy |
| 04/12/2000 | EP0991638A1 NOVEL GUANIDINE MIMICS AS FACTOR Xa INHIBITORS |
| 04/12/2000 | EP0991637A1 Benzo(5,6)cyclohepta(1,2-b)pyridine derivatives as farnesyl protein transferase inhibitors |
| 04/12/2000 | EP0991627A1 Pyrimidinone compounds, pharmaceutical compositions containing the compounds and the process for preparing the same |
| 04/12/2000 | EP0991625A2 Inhibitors of factor xa with a neutral p1 specificity group |
| 04/12/2000 | EP0991624A1 Phenylalkyl derivatives with thrombin-inhibiting effect |
| 04/12/2000 | EP0991623A2 Quinoline-indole antimicrobial agents, uses and compositions related thereto |
| 04/12/2000 | EP0991621A1 Novel heterocyclic compounds |
| 04/12/2000 | EP0991411A1 Treatment for pulmonary fibrosis |
| 04/12/2000 | EP0991410A1 Gastrokinetic bicyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivates |
| 04/12/2000 | EP0766825A4 Preparation of derivatized 10,10'-substituted-9,9'-biacridine luminescent molecules and signal solutions |
| 04/12/2000 | CN1250447A 4-(3-heterocyclyl-1-benzoyl) pyrazoles and their use as herbicides |
| 04/12/2000 | CN1250446A Pyrazole derivatives as herbicides |
| 04/12/2000 | CN1250445A Sulfamide-metalloprotease inhibitors |
| 04/12/2000 | CN1250442A Substituted aminosalicyclic acid amides with fungicidal effect and intermediate products for production thereof |
| 04/12/2000 | CN1250440A Process for preparing pyrazole derivatives |
| 04/12/2000 | CN1051313C 5-arylindole derivatives and its use, pharmaceutical composition containing the same and intermediate for preparing them |
| 04/12/2000 | CN1051304C Process for preparing aqueous nicotinaldehyde |
| 04/11/2000 | US6048981 Magnesium omeprazole and process for its preparation |
| 04/11/2000 | US6048877 Cardiovascular disorders |
| 04/11/2000 | US6048875 Benzothiophene, benzofuran and indole compounds |
| 04/11/2000 | US6048869 Reductase inhibitors |
| 04/11/2000 | US6048866 Substituted 2-anilinopryimidines useful as protein kinase inhibitors |
| 04/11/2000 | US6048864 Benign prostatic hyperplasia |
| 04/11/2000 | US6048861 Osteoporosis; bone disorders; cardiovascular disorders; antiinflammatroy agents; wound healing agents |
| 04/11/2000 | US6048856 Heterocyclic compounds |
| 04/11/2000 | US6048842 Antidiabetic agent |
| 04/11/2000 | US6048824 2-nitromethylidene/2-cyanimino/2-nitro-imino-pyrrolidines and piperidines, intermediates, and their use as pesticides |
| 04/11/2000 | US6048823 Pyridone derivatives and herbicides |
| 04/08/2000 | CA2285120A1 Heterocycles |
| 04/06/2000 | WO2000018767A2 2-piperazino alkylamino benzoazole derivatives: dopamine receptor subtype specific ligands |
| 04/06/2000 | WO2000018764A1 Benzimidazolinyl piperidines as cgrp ligands |
| 04/06/2000 | WO2000018761A1 Substituted 3-cyanoquinolines as protein tyrosine kinases inhibitors |
| 04/06/2000 | WO2000018760A1 1,3-benzodiazepines with integrin inhibitory activity for use in the treatment of inflammatory disorders |
| 04/06/2000 | WO2000018759A1 Phenylalanine derivatives as alpha 4 integrin inhibitors |
| 04/06/2000 | WO2000018758A1 Pyrimidone derivatives |
| 04/06/2000 | WO2000018742A1 Sulfonyltriazol derivatives and their use for combating micro-organisms |
| 04/06/2000 | WO2000018740A1 Substituted 3-cyanoquinolines as protein tyrosine kinases inhibitors |
| 04/06/2000 | WO2000018738A1 Benzamide derivatives and their use as cytokine inhibitors |
| 04/06/2000 | WO2000018734A1 Novel substituted indolinones with an inhibitory effect on various kinases and cyclin/cdk complexes |
| 04/06/2000 | WO2000018409A1 Use of certain drugs for treating nerve root injury |
| 04/06/2000 | WO2000018404A1 Antibiotic compositions for treatment of the eye, ear and nose |
| 04/06/2000 | WO2000018403A1 Radiolabeled neurokinin-1 receptor antagonists |
| 04/06/2000 | WO2000018391A1 Drugs for improving vesical excretory strength |
| 04/06/2000 | WO2000018361A2 Method of treating hair loss using sulfonamides |
| 04/06/2000 | WO2000018358A2 Method of treating hair loss using ketoamides |
| 04/06/2000 | WO2000018352A2 A method for treating inflammatory diseases by administering a thrombin inhibitor |
| 04/06/2000 | WO2000006173A8 5-ht1f agonists |
| 04/06/2000 | WO2000001704A3 Benzimidazoles, production thereof and use thereof as medicaments |
| 04/06/2000 | WO1999061013A3 COMPOUNDS HAVING IgE AFFECTING PROPERTIES |